Skip to main content
INmune Bio, Inc. (INMB)
NASDAQ: INMB · IEX Real-Time Price · USD
8.07
-0.35 (-4.16%)
Jul 2, 2024, 4:00 PM EDT - Market closed

INmune Bio Revenue

INmune Bio had revenue of $131.00K in the twelve months ending March 31, 2024, down -47.39% year-over-year. Revenue in the quarter ending March 31, 2024 was $14.00K, a -63.16% decrease year-over-year. In the year 2023, INmune Bio had annual revenue of $155.00K, a decrease of -58.56%.

Revenue (ttm)
$131.00K
Revenue Growth
-47.39%
P/S Ratio
1,218.66
Revenue / Employee
$11,909
Employees
11
Market Cap
159.64M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023155.00K-219.00K-58.56%
Dec 31, 2022374.00K193.00K106.63%
Dec 31, 2021181.00K170.00K1,545.45%
Dec 31, 202011.00K--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
High Tide 503.78M
Butterfly Network 68.08M
Biodesix 54.85M
908 Devices 50.73M
Fennec Pharmaceuticals 44.95M
Abeona Therapeutics 3.50M
Revenue Rankings

INMB News

More News